Pamala Pawloski, PharmD
Clinical pharmacy researcher
Joined the Institute
Pharm.D. North Dakota State University; pharmacy practice residency and oncology pharmacy practice residency, University of Kentucky; clinical pharmacology fellowship, University of Texas M.D. Anderson Cancer Center.
Site primary investigator (PI) for the Cancer Research Network (CRN) within the HMO Research Network (HMORN) and the U.S. Food and Drug Administration-sponsored Mini-Sentinel Drug Surveillance Program.
Oncology clinical pharmacy, clinical pharmacology, improving patient care and outcomes by improving medication management through enhanced identification of adverse reactions and subsequent reporting, increased medical therapy-management programs, and application of pharmacogenomic testing methods to enhance treatment optimization.